BACKGROUND: Microsatellite instability (MSI) is one of the leading mechanisms for the carcinogenesis of gastric cancer. Its prognostic value is controversial. METHODS: Between May 1988 and Oct 2003, a total of 214 gastric cancer patients undergoing curative surgery were enrolled, and their MSI statuses were classified as MSI-H (high) or MSI-L/S (low/stable). The clinicopathologic characteristics of MSI-H and MSI-L/S gastric cancers were compared. RESULTS: The MSI-H tumors accounted for 11.7 % (n = 25) of the 214 total gastric cancers. Although not statistically significant, the MSI-H gastric cancers were more frequently located in the lower third of the stomach (64 % vs. 49.2 %) and were more often the intestinal type (72 % vs. 61.4 %) compared to the MSI-L/S gastric cancers. The MSI-H gastric cancers had a significantly better 5-year overall survival (OS) rate (68 % vs. 47.6 %, p = 0.030) and a trend of a better 3-year disease-free survival rate (71.8 % vs. 55.2 %, p = 0.076) compared to the MSI-L/S gastric cancers. A multivariate analysis revealed that pathologic TNM stage and MSI status were the independent prognostic factors for OS after curative surgery. CONCLUSIONS: Compared to MSI-L/S tumors, MSI-H tumors are associated with a better OS rate for gastric cancer patients after R0 resection.
BACKGROUND: Microsatellite instability (MSI) is one of the leading mechanisms for the carcinogenesis of gastric cancer. Its prognostic value is controversial. METHODS: Between May 1988 and Oct 2003, a total of 214 gastric cancerpatients undergoing curative surgery were enrolled, and their MSI statuses were classified as MSI-H (high) or MSI-L/S (low/stable). The clinicopathologic characteristics of MSI-H and MSI-L/S gastric cancers were compared. RESULTS: The MSI-H tumors accounted for 11.7 % (n = 25) of the 214 total gastric cancers. Although not statistically significant, the MSI-H gastric cancers were more frequently located in the lower third of the stomach (64 % vs. 49.2 %) and were more often the intestinal type (72 % vs. 61.4 %) compared to the MSI-L/S gastric cancers. The MSI-H gastric cancers had a significantly better 5-year overall survival (OS) rate (68 % vs. 47.6 %, p = 0.030) and a trend of a better 3-year disease-free survival rate (71.8 % vs. 55.2 %, p = 0.076) compared to the MSI-L/S gastric cancers. A multivariate analysis revealed that pathologic TNM stage and MSI status were the independent prognostic factors for OS after curative surgery. CONCLUSIONS: Compared to MSI-L/S tumors, MSI-H tumors are associated with a better OS rate for gastric cancerpatients after R0 resection.
Authors: A Riccio; L A Aaltonen; A K Godwin; A Loukola; A Percesepe; R Salovaara; V Masciullo; M Genuardi; M Paravatou-Petsotas; D E Bassi; B A Ruggeri; A J Klein-Szanto; J R Testa; G Neri; A Bellacosa Journal: Nat Genet Date: 1999-11 Impact factor: 38.330
Authors: Shih-Ching Chang; Jen-Kou Lin; Shung Haur Yang; Huann-Sheng Wang; Anna Fen-Yau Li; Chin-Wen Chi Journal: Int J Cancer Date: 2006-04-01 Impact factor: 7.396
Authors: J Schumacher; P Malfertheiner; M Venerito; T Stolze; S Franke; J Haybaeck; M Moehler; P P Grimminger; H Lang; W Roth; I Gockel; N Kreuser; H Bläker; C Wittekind; F Lordick; M Vieth; L Veits; O Waidmann; P Lingohr; U Peitz; C Schildberg; M Kruschewski; N Vassos; E Goni; C J Bruns; K Ridwelski; S Wolff; H Lippert Journal: J Cancer Res Clin Oncol Date: 2022-02-25 Impact factor: 4.553
Authors: Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz Journal: World J Gastroenterol Date: 2016-02-28 Impact factor: 5.742